Abstract
We evaluated the in vitro susceptibilities of 217 zygomycetes to amphotericin B, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and flucytosine. The significant in vitro activity of posaconazole against several species appears to support its reported clinical efficacy. Decreased susceptibility to amphotericin B was noted with Cunninghamella bertholletiae.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2587-2590 |
| Number of pages | 4 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 51 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2007 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Fingerprint Dive into the research topics of 'In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents'. Together they form a unique fingerprint.
Cite this
Almyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., & Kusne, S. (2007). In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrobial agents and chemotherapy, 51(7), 2587-2590. https://doi.org/10.1128/AAC.00452-07